As reported, HNSS treatment through appropriate administration effectively recovered mitochondrial function, decreased Aβ deposition and tau hyperphosphorylation, rescued cholinergic neuron loss, and ameliorated cognitive deficit in 3xTg-AD mice [36]. The gene discussed is MAPT; the disease is Cognitive impairment.